BIIB
Biogen Inc.
215.50$
-1.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 12.1% | 11.5% | 12.5% | 13.3% | 13.5% | 13.6% | 13.4% | 19.2% | 22.4% | 25.8% | 23.9% | 29.5% | |
| 87.9% | 88.5% | 87.5% | 86.7% | 86.5% | 86.4% | 86.6% | 80.8% | 77.6% | 74.2% | 76.1% | 70.5% | |
| 19.5% | 18.7% | 17.2% | 19.3% | 20.1% | 19.3% | 33.7% | 31.0% | 25.5% | 27.5% | 25.7% | 19.9% | |
| 22.0% | 18.6% | 16.1% | 15.2% | 15.0% | 15.9% | 17.9% | 23.5% | 23.1% | 24.7% | 24.0% | 24.8% | |
| 47.0% | 43.0% | 42.5% | 43.2% | 42.7% | 37.4% | 52.4% | 55.4% | 49.2% | 52.9% | 50.4% | 51.3% | |
| 40.9% | 45.4% | 45.0% | 43.6% | 43.8% | 49.0% | 34.2% | 25.4% | 28.4% | 21.3% | 25.7% | 19.1% | |
| 0.3% | 0.9% | 2.3% | 2.0% | 1.5% | 1.3% | 1.7% | 2.3% | 2.4% | 2.5% | 2.6% | 2.5% | |
| 40.5% | 44.2% | 43.1% | 41.8% | 43.9% | 49.0% | 37.6% | 16.2% | 35.3% | 13.2% | 19.7% | 14.3% | |
| 10.2% | 10.8% | 10.8% | 20.0% | 10.6% | 8.1% | 7.4% | 0.5% | 6.2% | 1.4% | 2.8% | 1.1% | |
| 30.2% | 33.0% | 32.3% | 20.7% | 32.9% | 41.0% | 29.8% | 14.2% | 29.9% | 11.8% | 16.9% | 13.2% | |
| 47.5% | 52.2% | 55.4% | 53.8% | 52.1% | 53.8% | 38.0% | 35.7% | 34.8% | 24.2% | 31.0% | 31.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.